Kristina Sjöblom Nygren

Dr. Kristina Sjöblom Nygren, MD, is a Chief Medical Officer at Egetis Therapeutics AB and an Independent Director at Infant Bacterial Therapeutics AB.
She is on the Board of Directors at Infant Bacterial Therapeutics AB.
Dr. Sjöblom Nygren was previously employed as a Chief Medical Officer, EVP & Head-Development by Santhera Pharmaceuticals Holding AG, a Group Director-Development by Astrazeneca AG, a Medical Director by Pfizer AG, and a Vice President & Head-Clinical Development by Swedish Orphan Biovitrum AB.
She received her doctorate degree from Karolinska Institutet.